Nephros, Inc.
NEPH
$1.89
-$0.08-4.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -0.53% | 0.03% | 12.79% | 22.14% | 42.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.53% | 0.03% | 12.79% | 22.14% | 42.72% |
| Cost of Revenue | -6.75% | -6.59% | -5.08% | -2.70% | 10.96% |
| Gross Profit | 3.78% | 4.76% | 28.68% | 46.81% | 78.11% |
| SG&A Expenses | -13.86% | -0.87% | 9.35% | 18.44% | 17.37% |
| Depreciation & Amortization | -36.92% | -30.59% | -18.40% | -7.66% | 3.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.58% | -4.43% | 1.44% | 6.45% | 10.62% |
| Operating Income | 100.38% | 41.36% | 49.58% | 51.94% | 63.25% |
| Income Before Tax | 105.65% | 43.35% | 52.22% | 52.42% | 63.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 104.70% | 43.35% | 52.22% | 52.42% | 63.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 104.70% | 49.48% | 73.53% | 74.58% | 78.66% |
| EBIT | 100.38% | 41.36% | 49.58% | 51.94% | 63.25% |
| EBITDA | 110.37% | 43.13% | 51.37% | 53.51% | 65.39% |
| EPS Basic | 104.55% | 50.17% | 73.97% | 74.87% | 78.89% |
| Normalized Basic EPS | 105.38% | 46.74% | 56.75% | 57.68% | 66.97% |
| EPS Diluted | 101.94% | 55.91% | 74.20% | 75.03% | 79.33% |
| Normalized Diluted EPS | 105.38% | 46.74% | 56.75% | 57.68% | 66.97% |
| Average Basic Shares Outstanding | 1.34% | 1.53% | 1.72% | 1.20% | 0.91% |
| Average Diluted Shares Outstanding | 1.46% | 1.62% | 1.72% | 1.20% | 0.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |